Author: dumbcapital

Home run exits happen stealthily for biotech

Joanna Glasner Contributor More posts by this contributor While tech waffles on going public, biotech IPOs boom Shoe startups aren’t dragging their feet Startup exit tallies commonly underestimate biotech returns. Unlike most tech deals, the biggest profits in bio often come long after an IPO or acquisition. Take Juno Therapeutics, a publicly traded cancer immunology company…

Read More

Are Russian-spy hookers targeting tech leaders and VCs at infamous Silicon Valley ‘cougar nights’?

Suspected Russian “honeypot” prostitutes targeting tech execs and VCs in an infamous Silicon Valley lounge provide a salacious illustration of the region’s spy problem — but much of the espionage here looks like business as usual, according to a new report. The West Coast is seeing a “full-on epidemic of espionage” centered largely on Silicon…

Read More